How Long to Hold Xarelto Before Surgery: Procedure, Recovery and Results

How long to hold Xarelto before surgery depends on the operation’s bleeding risk, kidney function, the reason for anticoagulation and whether spinal or epidural anesthesia is planned. Many people stop rivaroxaban 1 to 2 days before an elective procedure, but the exact plan must be provided by the prescribing clinician and surgical team.

Overview: planning Xarelto safely around surgery

Xarelto is the brand name for rivaroxaban, a direct oral anticoagulant (DOAC). It helps prevent harmful blood clots in conditions such as atrial fibrillation, deep vein thrombosis and pulmonary embolism. Because it reduces clotting, it may increase bleeding during an operation, biopsy, dental procedure or invasive test.

Before a planned procedure, clinicians balance two important risks: bleeding if anticoagulation is continued and clotting if it is interrupted for too long. The safest plan is coordinated between the surgeon or procedural clinician, anesthesiologist and the clinician managing the anticoagulant. Patients should bring an up-to-date list of all medicines, supplements and previous bleeding or clotting events to their preoperative assessment.

Information in this article is general education rather than a personal medication plan. Xarelto should never be stopped, restarted or replaced with another blood thinner without individualized medical advice.

How long do you hold Xarelto prior to surgery?

For many elective procedures, Xarelto is held for about 24 hours before a low-bleeding-risk procedure and about 48 hours before a higher-bleeding-risk operation. This often means skipping one dose for a lower-risk procedure or two doses for a higher-risk procedure when Xarelto is taken once daily. However, the precise last-dose time matters and should be written clearly in the preoperative instructions.

Examples of procedures with higher bleeding concern can include major abdominal, orthopedic, cancer, heart, brain or spine surgery. Some minor skin, eye, dental or diagnostic procedures may have a lower bleeding risk, and in selected cases anticoagulation may be continued or interrupted only briefly. The clinician performing the procedure determines its bleeding category.

Spinal anesthesia, epidural anesthesia and procedures involving the spine require especially careful timing because bleeding near the spinal cord can be serious. These situations often require a longer period off Xarelto than routine low-risk procedures. Patients should tell the anesthesia team if they use Xarelto, even if they believe they have already stopped it.

How long does Xarelto 20 mg stay in your system?

A 20 mg dose of Xarelto does not remain at its full effect indefinitely. In many adults, rivaroxaban has a half-life of roughly 5 to 9 hours, while the effect may last longer in older adults, people with reduced kidney or liver function, or those taking medicines that affect how rivaroxaban is processed.

As a practical guide, most of the medicine is cleared over several half-lives, which is why clinicians often use a 1- to 2-day interruption for planned procedures. A dose of 20 mg may be the standard strength for some indications, but dose strength alone does not determine the hold period. The procedure’s bleeding risk and a person’s health profile are more important.

Routine blood tests such as INR do not reliably show whether Xarelto is still active. In complex or urgent situations, clinicians may use specialized testing where available, but decisions are usually based on the timing of the last dose, kidney function, urgency and anticipated bleeding risk.

When would you hold Xarelto?

Xarelto may be held before elective surgery, invasive procedures or certain dental treatments when the expected bleeding risk outweighs the short-term risk of interruption. It may also need reassessment after significant bleeding, serious injury, acute illness affecting kidney or liver function, or when another medicine is prescribed that can meaningfully increase bleeding risk.

Holding Xarelto is not automatically appropriate for every procedure. For example, some minor procedures can be performed safely with no interruption or with a modified dosing schedule. Stopping unnecessarily can increase the chance of stroke or recurrent venous thromboembolism in people who need ongoing anticoagulation.

Clinicians also consider why Xarelto was prescribed. A person with a recent blood clot, certain high-risk atrial fibrillation features, or a history of recurrent clots may need a more carefully coordinated plan. In most people using DOACs, temporary injectable “bridging” anticoagulation is not routinely used, because it can increase bleeding without clear benefit.

When to hold blood thinners before surgery?

Blood thinners are not all managed in the same way. Xarelto and other DOACs generally have shorter interruption schedules than warfarin because they work and clear from the body more quickly. Antiplatelet medicines, such as aspirin or clopidogrel, have different effects on platelets and may require different instructions.

The surgical team should know about every medicine that can affect bleeding, including prescription anticoagulants, antiplatelet medicines, anti-inflammatory pain medicines, herbal products and supplements. Patients should not assume that an over-the-counter product is harmless before surgery. Some supplements, including those marketed for circulation or joint health, may affect bleeding or interact with medications.

A useful preoperative plan states the date and time of the final dose, whether any medicine is to be taken on the day of surgery, and when treatment can safely resume. It should also identify which clinician to contact if the procedure is delayed, cancelled, or changed to one with a different bleeding risk.

Procedure pathway: assessment, surgery and restarting Xarelto

During preoperative assessment, the team reviews the planned procedure, current Xarelto schedule, indication for anticoagulation, kidney and liver health, prior bleeding, other medicines and anesthesia plan. Tests may be arranged if they are relevant to the surgery or a person’s overall health, although there is no routine test that precisely predicts residual Xarelto effect in every setting.

On the day of surgery, patients should follow the agreed medication and fasting instructions. They should report the time of their last Xarelto dose and mention any unexpected bleeding, falls, new illness or missed doses. For urgent surgery, clinicians assess how recently Xarelto was taken and may delay a procedure when medically safe or use measures to manage anticoagulant effect when needed.

After surgery, Xarelto is restarted only when the surgical team is satisfied that bleeding is controlled and the person can take oral medication safely. After some low-risk procedures this may be about 24 hours later; after major surgery or procedures with a high bleeding risk, it may be 48 to 72 hours or longer. Mechanical clot-prevention measures or preventive-dose medication may be considered during recovery when appropriate.

The expected benefit of a structured plan is lower risk of avoidable surgical bleeding while minimizing time without protection against blood clots. Possible complications include wound bleeding, bruising, internal bleeding or, less commonly, a clot during interruption. Clear communication and individualized scheduling are central to safe care.

Recovery, self-care and when to seek medical care

During recovery, patients should take Xarelto exactly as instructed and should not “catch up” missed doses unless a clinician specifically advises it. They should avoid starting anti-inflammatory pain relievers, aspirin, herbal remedies or supplements without checking with the care team, as these can affect bleeding. The surgical team can recommend suitable pain relief and activity progression.

Patients should contact their surgical or anticoagulation team promptly for persistent wound bleeding, rapidly worsening bruising, blood in urine or stool, vomiting blood, severe headache, fainting, unusual weakness, chest pain, sudden shortness of breath, or one-sided leg swelling or pain. Emergency care is appropriate for heavy bleeding, symptoms of stroke, severe breathing difficulty or collapse.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can coordinate perioperative anticoagulation planning and surgical care for international patients. A written plan shared across the patient’s medical team can help support a safer, more predictable recovery.

Frequently asked questions

Should Xarelto be stopped before all dental procedures?

No. Many routine dental procedures can be performed without stopping Xarelto or with only a limited adjustment. The dentist and prescribing clinician should decide together, particularly for extractions, gum surgery or multiple procedures. Local measures can often help control dental bleeding.

Can a patient stop Xarelto two days before surgery on their own?

No. Although a two-day hold is common before some higher-bleeding-risk operations, it is not appropriate for everyone. The timing must account for kidney function, surgery type, anesthesia and the reason Xarelto was prescribed.

When can Xarelto be restarted after surgery?

Xarelto is generally restarted after the surgical team confirms adequate bleeding control. This may be around 24 hours after a low-risk procedure and 48 to 72 hours or longer after high-risk surgery. The patient should follow the written postoperative instructions rather than restarting based on a general timetable.

Is heparin bridging needed when Xarelto is stopped?

Most people taking Xarelto do not need heparin bridging during a short planned interruption. Bridging can increase bleeding risk and is usually reserved for selected clinical situations. A clinician familiar with the patient’s clotting risk should make this decision.

What happens if a patient accidentally takes Xarelto before surgery?

The patient should contact the surgeon, anesthesia team or preoperative clinic immediately and report the dose and time it was taken. The procedure may still be able to proceed, be delayed, or require a revised plan depending on urgency and bleeding risk. The patient should not take further doses unless instructed.

Does kidney disease change how long Xarelto should be held?

Yes. Reduced kidney function can affect how long anticoagulant activity persists, although the extent varies by medicine and individual circumstances. The care team may recommend a longer interruption or additional assessment before surgery.

References

• American College of Cardiology
• American College of Chest Physicians
• European Heart Rhythm Association
• United States Food and Drug Administration
• National Health Service

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.